Sr. Diego Baranda Martínez-Abascal

Institutions of which it is part

I did my Bachelor in Biology at the UIB and I subsequently studied the Master's in Molecular Biotechnology at the University of Barcelona (UB). Before arriving at the VHIR I had an internship contract at the Institute of BioEngineering of Catalonia (IBEC) and I carried out a research stay at the Institute of Molecular Biology of Barcelona (IBMB - Spanish National Research Council, CSIC). The obtention of a University Teacher Training grant (FPU) allowed me to join the VHIR in order to carry out my doctoral thesis in the Drug Delivery and Targeting group. My project is based on the development of an alternative therapy for pancreatic cancer using genetically modified extracellular vesicles (EVs). I'm also working on other projects that pursue the development of the use of EVs for the treatment of minority diseases. In addition, I continue my training with the doctoral courses of the UB and I participate in scientific dissemination activities organized by the VHIR, among other things. Thanks for your interest :)

Curriculum

Bachelor in Biology UIB. Erasmus at the University of Radboud, Nijmegen (Netherlands). Bachelor¡s thesis at the Balearic Islands Health Research Institute (IdISBa). Graduated in 2019, average grade of 8.92. Granted with the Scolarship for the Promotion of Academic Excellence 2018-2019 (GOIB).
Master of Molecular Biotechnology at the University of Barcelona (UB). Master's thesis at the Institute of BioEngineering of Barcelona (IBEC), granted with the IBEC Master Program Scholarship 2019. Graduated in 2020, average grade of 9.
Research stay at the Institute of Molecular Biology of Barcelona (IBMB), Spanish National Research Council (CSIC), granted with the JAE Intro 2020 Fellowship from the Ministry of Science and Innovation of Spain.
PhD at the Drug Delivery and Targeting (DDT) group of the VHIR. Obtention of a grant for University Teacher Training (FPU) awarded by the spanish Ministry of Universities. Development of a nanomedical alternative therapy for pancreatic cancer using genetically modified extracellular vesicles (EVs).
Level C2 in English issued by Cambridge English (CAE). Level B1 in French issued by the Official School of Languages ​​(EOI).
Diego Baranda Martínez-Abascal

Institutions

Vall Hebron Institut de Recerca

Predoctoral researcher

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)

Subscribe to our newsletters and be a part of Campus Life

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.